Please use this identifier to cite or link to this item:
https://scidar.kg.ac.rs/handle/123456789/15770
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Popovic D. | - |
dc.contributor.author | Koufakis T. | - |
dc.contributor.author | Kovacevic, Bojan | - |
dc.contributor.author | RIZZO, Manfredi | - |
dc.contributor.author | Papanas N. | - |
dc.date.accessioned | 2023-02-08T15:45:55Z | - |
dc.date.available | 2023-02-08T15:45:55Z | - |
dc.date.issued | 2022 | - |
dc.identifier.issn | 1474-0338 | - |
dc.identifier.uri | https://scidar.kg.ac.rs/handle/123456789/15770 | - |
dc.rights | info:eu-repo/semantics/restrictedAccess | - |
dc.source | Expert Opinion on Drug Safety | - |
dc.title | Immune checkpoint inhibitors-induced diabetes mellitus: a growing clinical presentation requiring our attention | - |
dc.type | editorial | - |
dc.identifier.doi | 10.1080/14740338.2022.2134343 | - |
dc.identifier.scopus | 2-s2.0-85139867064 | - |
Appears in Collections: | Faculty of Medical Sciences, Kragujevac |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
PaperMissing.pdf Restricted Access | 29.86 kB | Adobe PDF | View/Open |
Items in SCIDAR are protected by copyright, with all rights reserved, unless otherwise indicated.